ARTIVION, INC. - AORT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 04, 2026 | EVP, COO, CFO & Treasurer | S | D | 6,316.0 | 37.7756 | 238,590.69 | 210,827.0 | View | |
| Mar 04, 2026 | EVP, COO, CFO & Treasurer | A | A | 40,874.0 | 0.0 | 0.0 | 217,143.0 | View | |
| Mar 04, 2026 | Chief Commercial Officer | S | D | 4,573.0 | 37.7756 | 172,747.82 | 230,794.0 | View | |
| Mar 04, 2026 | Chief Commercial Officer | A | A | 28,845.0 | 0.0 | 0.0 | 235,367.0 | View | |
| Mar 04, 2026 | SVP, Clinical & MD Affair | S | D | 2,149.0 | 37.7756 | 81,179.76 | 60,097.0 | View | |
| Mar 04, 2026 | SVP, Clinical & MD Affair | A | A | 21,838.0 | 0.0 | 0.0 | 62,246.0 | View | |
| Mar 04, 2026 | SVP, General Counsel | S | D | 8,962.0 | 38.0 | 340,556.0 | 185,095.0 | View | |
| Mar 04, 2026 | SVP, General Counsel | S | D | 3,843.0 | 37.7756 | 145,171.63 | 194,057.0 | View | |
| Mar 04, 2026 | SVP, General Counsel | A | A | 27,795.0 | 0.0 | 0.0 | 197,900.0 | View | |
| Mar 04, 2026 | VP, Chief Accounting Officer | S | D | 901.0 | 37.7756 | 34,035.82 | 139,088.0 | View | |
| Mar 04, 2026 | VP, Chief Accounting Officer | A | A | 7,475.0 | 0.0 | 0.0 | 139,989.0 | View | |
| Mar 04, 2026 | President & CEO | S | D | 17,887.0 | 37.7756 | 675,692.16 | 947,275.0 | View | |
| Mar 04, 2026 | President & CEO | A | A | 116,948.0 | 0.0 | 0.0 | 965,162.0 | View | |
| Mar 03, 2026 | Chief Commercial Officer | S | D | 2,784.0 | 38.0249 | 105,861.32 | 206,522.0 | View | |
| Mar 03, 2026 | EVP, COO, CFO & Treasurer | S | D | 5,178.0 | 38.0249 | 196,892.93 | 176,269.0 | View | |
| Mar 03, 2026 | SVP, General Counsel | S | D | 2,183.0 | 38.0249 | 83,008.36 | 170,105.0 | View | |
| Mar 03, 2026 | President & CEO | S | D | 14,911.0 | 38.0249 | 566,989.28 | 848,214.0 | View | |
| Mar 03, 2026 | SVP, Clinical & MD Affair | S | D | 1,513.0 | 38.0249 | 57,531.67 | 40,408.0 | View | |
| Mar 03, 2026 | VP, Chief Accounting Officer | S | D | 641.0 | 38.0249 | 24,373.96 | 132,514.0 | View | |
| Feb 25, 2026 | EVP, COO, CFO & Treasurer | A | A | 37,482.0 | 0.0 | 0.0 | 181,447.0 | View | |
| Feb 25, 2026 | EVP, COO, CFO & Treasurer | S | D | 4,485.0 | 35.693 | 160,083.11 | 143,965.0 | View | |
| Feb 25, 2026 | EVP, COO, CFO & Treasurer | S | D | 4,981.0 | 37.588 | 187,225.83 | 148,450.0 | View | |
| Feb 25, 2026 | President & CEO | A | A | 97,030.0 | 0.0 | 0.0 | 863,125.0 | View | |
| Feb 25, 2026 | President & CEO | S | D | 13,936.0 | 35.693 | 497,417.65 | 766,095.0 | View | |
| Feb 25, 2026 | President & CEO | S | D | 20,962.0 | 37.588 | 787,919.66 | 780,031.0 | View | |
| Feb 25, 2026 | SVP, General Counsel | A | A | 20,085.0 | 0.0 | 0.0 | 172,288.0 | View | |
| Feb 25, 2026 | SVP, General Counsel | S | D | 1,668.0 | 35.693 | 59,535.92 | 152,203.0 | View | |
| Feb 25, 2026 | SVP, General Counsel | S | D | 3,079.0 | 37.588 | 115,733.45 | 153,871.0 | View | |
| Feb 25, 2026 | SVP, Clinical & MD Affair | S | D | 1,259.0 | 35.693 | 44,937.49 | 41,921.0 | View | |
| Feb 25, 2026 | SVP, Clinical & MD Affair | S | D | 2,423.0 | 37.588 | 91,075.72 | 43,180.0 | View | |
| Feb 25, 2026 | VP, Chief Accounting Officer | A | A | 5,658.0 | 0.0 | 0.0 | 133,155.0 | View | |
| Feb 25, 2026 | VP, Chief Accounting Officer | S | D | 830.0 | 35.693 | 29,625.19 | 127,497.0 | View | |
| Feb 25, 2026 | VP, Chief Accounting Officer | S | D | 1,731.0 | 37.588 | 65,064.83 | 128,327.0 | View | |
| Feb 25, 2026 | Chief Commercial Officer | A | A | 20,438.0 | 0.0 | 0.0 | 209,306.0 | View | |
| Feb 25, 2026 | Chief Commercial Officer | S | D | 2,075.0 | 35.693 | 74,062.98 | 188,868.0 | View | |
| Feb 25, 2026 | Chief Commercial Officer | S | D | 3,773.0 | 37.588 | 141,819.52 | 190,943.0 | View | |
| Dec 17, 2025 | Chief Commercial Officer | S | D | 5,000.0 | 45.11 | 225,550.0 | 193,842.0 | View | |
| Dec 09, 2025 | VP, Chief Accounting Officer | S | D | 4,572.0 | 44.419 | 203,083.67 | 130,058.0 | View | |
| Dec 04, 2025 | SVP, General Counsel | S | D | 5,267.0 | 45.3 | 238,595.1 | 156,093.0 | View | |
| Dec 04, 2025 | SVP, General Counsel | S | D | 2,048.0 | 45.3 | 92,774.4 | 161,360.0 | View | |
| Dec 04, 2025 | President & CEO | M | D | 30,921.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 04, 2025 | President & CEO | S | D | 30,921.0 | 45.461 | 1,405,699.58 | 800,993.0 | View | |
| Dec 04, 2025 | President & CEO | M | A | 30,921.0 | 29.62 | 915,880.02 | 831,914.0 | View | |
| Dec 03, 2025 | President & CEO | M | D | 30,921.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 03, 2025 | President & CEO | S | D | 30,921.0 | 45.559 | 1,408,729.84 | 800,993.0 | View | |
| Dec 03, 2025 | President & CEO | M | A | 30,921.0 | 29.62 | 915,880.02 | 831,914.0 | View | |
| Dec 02, 2025 | VP, Chief Accounting Officer | G | D | 750.0 | 0.0 | 0.0 | 134,630.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | D | 27,075.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | D | 20,301.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | S | D | 8,370.0 | 45.345 | 379,537.65 | 44,753.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | S | D | 18,705.0 | 44.91 | 840,041.55 | 53,123.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | A | 27,075.0 | 11.03 | 298,637.25 | 71,828.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | S | D | 5,715.0 | 45.346 | 259,152.39 | 44,753.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | S | D | 14,586.0 | 44.919 | 655,188.53 | 50,468.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | A | 20,301.0 | 18.44 | 374,350.44 | 65,054.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | D | 1,355.0 | 0.0 | 0.0 | 27,075.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | D | 2,033.0 | 0.0 | 0.0 | 20,301.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | S | D | 1,355.0 | 44.278 | 59,996.69 | 44,753.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | A | 1,355.0 | 11.03 | 14,945.65 | 46,108.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | S | D | 2,033.0 | 44.315 | 90,092.4 | 44,753.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | M | A | 2,033.0 | 18.44 | 37,488.52 | 46,786.0 | View | |
| Nov 24, 2025 | SVP, Clinical & MD Affair | S | D | 11,888.0 | 44.14 | 524,736.32 | 44,753.0 | View | |
| Nov 19, 2025 | — | S | D | 4,200.0 | 45.098 | 189,411.6 | 27,189.0 | View | |
| Nov 18, 2025 | Chief Commercial Officer | M | D | 6,394.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 18, 2025 | Chief Commercial Officer | M | D | 6,393.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 18, 2025 | Chief Commercial Officer | S | D | 6,394.0 | 45.17 | 288,816.98 | 198,842.0 | View | |
| Nov 18, 2025 | Chief Commercial Officer | M | A | 6,394.0 | 29.62 | 189,390.28 | 205,236.0 | View | |
| Nov 18, 2025 | Chief Commercial Officer | S | D | 6,393.0 | 44.67 | 285,575.31 | 198,842.0 | View | |
| Nov 18, 2025 | Chief Commercial Officer | M | A | 6,393.0 | 29.62 | 189,360.66 | 205,235.0 | View | |
| Nov 18, 2025 | SVP, General Counsel | M | D | 6,394.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 18, 2025 | SVP, General Counsel | M | D | 6,393.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 18, 2025 | SVP, General Counsel | S | D | 6,394.0 | 45.17 | 288,816.98 | 163,408.0 | View | |
| Nov 18, 2025 | SVP, General Counsel | M | A | 6,394.0 | 29.62 | 189,390.28 | 169,802.0 | View | |
| Nov 18, 2025 | SVP, General Counsel | S | D | 6,393.0 | 45.0 | 287,685.0 | 163,408.0 | View | |
| Nov 18, 2025 | SVP, General Counsel | M | A | 6,393.0 | 29.62 | 189,360.66 | 169,801.0 | View | |
| Nov 18, 2025 | VP, Chief Accounting Officer | S | D | 6,000.0 | 45.73 | 274,380.0 | 135,380.0 | View | |
| Nov 14, 2025 | SVP, Clinical & MD Affair | S | D | 4,993.0 | 45.858 | 228,968.99 | 56,641.0 | View | |
| Nov 14, 2025 | SVP, General Counsel | S | D | 5,761.0 | 45.858 | 264,187.94 | 163,408.0 | View | |
| Nov 14, 2025 | President & CEO | S | D | 34,210.0 | 45.858 | 1,568,802.18 | 800,993.0 | View | |
| Nov 14, 2025 | Chief Commercial Officer | S | D | 6,563.0 | 45.858 | 300,966.05 | 198,842.0 | View | |
| Nov 14, 2025 | VP, Chief Accounting Officer | S | D | 3,482.0 | 45.858 | 159,677.56 | 141,380.0 | View | |
| Nov 12, 2025 | VP, Chief Accounting Officer | S | D | 1,789.0 | 44.619 | 79,823.39 | 144,862.0 | View | |
| Nov 12, 2025 | Chief Commercial Officer | S | D | 3,373.0 | 44.619 | 150,499.89 | 205,405.0 | View | |
| Nov 12, 2025 | President & CEO | S | D | 17,580.0 | 44.619 | 784,402.02 | 835,203.0 | View | |
| Nov 12, 2025 | SVP, General Counsel | M | D | 10,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 12, 2025 | SVP, General Counsel | S | D | 10,000.0 | 46.18 | 461,800.0 | 169,169.0 | View | |
| Nov 12, 2025 | SVP, General Counsel | M | A | 10,000.0 | 11.03 | 110,300.0 | 179,169.0 | View | |
| Nov 12, 2025 | SVP, General Counsel | S | D | 2,960.0 | 44.619 | 132,072.24 | 169,169.0 | View | |
| Nov 12, 2025 | SVP, Clinical & MD Affair | S | D | 2,566.0 | 44.619 | 114,492.35 | 61,634.0 | View |